3E0230MIntroduction of Antineoplastic, Monoclonal Antibody, into Muscle, Percutaneous Approach
- Billable / Specific Code
3E0230M is a billable ICD-10-PCS procedure code for Introduction of Antineoplastic, Monoclonal Antibody, into Muscle, Percutaneous Approach. It is valid on HIPAA claims for fiscal year 2027 (October 1, 2026 through September 30, 2027). The root operation Introduction involves putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products. In AHRQ's Clinical Classifications Software (CCSR), this procedure falls under Chemotherapy.
Code Identity
PCS Table Breakdown
Each ICD-10-PCS code is built from seven characters, each an axis of the procedure. Hover or tap the icons for the official CMS definitions.
| Position | Designation | Value | Meaning |
|---|---|---|---|
| 1 | Section | 3 | Administration |
| 2 | Body System | E | Physiological Systems and Anatomical Regions |
| 3 | Operation | 0 | Introduction |
| 4 | BodySystem/Region | 2 | Muscle |
| 5 | Approach | 3 | Percutaneous |
| 6 | Substance | 0 | Antineoplastic |
| 7 | Qualifier | M | Monoclonal Antibody |
In the ICD-10-PCS Alphabetic Index
These FY 2027 ICD-10-PCS Alphabetic Index entries lead to this code:
Clinical Classification (CCSR)
AHRQ groups this procedure code into these clinical categories.
Convert to ICD-9-PCS
Closest ICD-9-PCS equivalents for this code under the General Equivalence Mappings.
Similar Procedure Codes
Questions About 3E0230M
Is 3E0230M a billable code?
Yes. This is a complete seven-character ICD-10-PCS code, specific enough to report Introduction of Antineoplastic, Monoclonal Antibody, into Muscle, Percutaneous Approach on inpatient claims from October 1, 2026 through September 30, 2027.
What do the characters in 3E0230M mean?
The code breaks down character by character: the 1st character 3 is the Section (Administration); the 2nd character E is the Body System (Physiological Systems and Anatomical Regions); the 3rd character 0 is the Operation (Introduction); the 4th character 2 is the BodySystem/Region (Muscle); the 5th character 3 is the Approach (Percutaneous); the 6th character 0 is the Substance (Antineoplastic); the 7th character M is the Qualifier (Monoclonal Antibody).
What is the ICD-9-PCS equivalent of 3E0230M?
Under the General Equivalence Mappings, Introduction of Antineoplastic, Monoclonal Antibody, into Muscle, Percutaneous Approach crosswalks to ICD-9-PCS 99.28 (Injection or infusion of biological response modifier [BRM] as an antineoplastic agent). The mapping is approximate, so confirm it fits the documentation.
